Search results for "donors"

showing 10 items of 242 documents

Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication.

2011

Objective To demonstrate that the use of donor sperm leads to varying outcome rates and that its use has evolved. Design Retrospective observational cohort study. Setting University-affiliated private IVF setting. Patient(s) Women (2,934) undergoing donor insemination (DI) or IVF with donor sperm (IVF-D). Intervention(s) None. Main Outcome Measurement(s) We evaluated the distribution of the clinical indications for the use of donated sperm, studying the reproductive outcome. Result(s) A total of 1,663 DI (57%) and 1,271 IVF-D (43%) were performed. There were significant differences in the indications for the use of donated sperm (DI vs. IVF-D). Regarding pregnancy rates (PR), cases of nonob…

AdultMalemedicine.medical_specialtyPregnancy Ratemedicine.medical_treatmentPopulationFertilization in VitroBiologyRisk AssessmentIntracytoplasmic sperm injectionPregnancyRisk FactorsmedicineOdds RatioHumansAdvanced maternal ageSperm Injections Intracytoplasmiceducationreproductive and urinary physiologyAzoospermiaRetrospective StudiesGynecologyPregnancyeducation.field_of_studyIn vitro fertilisationChi-Square Distributionurogenital systemObstetricsObstetrics and GynecologySingle Personmedicine.diseaseSpermSpermatozoaTissue DonorsLogistic ModelsTreatment OutcomeReproductive MedicineSpainInsemination Artificial HeterologousFemaleDonor spermCohort studyMaternal AgeFertility and sterility
researchProduct

Partial T Cell-Depleted Peripheral Blood Stem Cell Transplantation from HLA-Identical Sibling Donors for Patients with Severe Aplastic Anemia

2019

We analyzed the outcomes of 26 consecutive patients with acquired severe aplastic anemia (SAA) undergoing peripheral blood stem cell transplantation (PBSCT) with partial ex vivo T cell depletion with a targeted T cell dose from HLA-identical sibling donors. The median patient age was 37 years (range, 3 to 63 years). Four patients with uncontrolled pneumonia at the time of transplantation died, on days +1, +2, +21, and +26. All evaluable patients engrafted, with a median time to neutrophil recovery of 11 days (range, 10 to 14 days) and a median time to platelet recovery of 19 days (range, 8 to 53 days). Two patients had transient grade I acute graft-versus-host disease (GVHD) with skin invol…

AdultMalemedicine.medical_specialtySevere aplastic anemiaAdolescentT-LymphocytesT cellGraft vs Host DiseaseHuman leukocyte antigenSeverity of Illness IndexGastroenterologyDisease-Free SurvivalLymphocyte DepletionHLA AntigensInternal medicinemedicineHumansCumulative incidenceSiblingChildAllogeneic stem cell transplantation Ex vivo T cell depletion Matched sibling donor Severe aplastic anemiaEx vivo T cell depletionMatched sibling donorPeripheral Blood Stem Cell TransplantationTransplantationbusiness.industryHistocompatibility TestingSiblingsAnemia AplasticHematologyMiddle AgedAllograftsmedicine.diseaseSevere Aplastic AnemiaTissue DonorsAllogeneic stem cell transplantationSurvival RateTransplantationPneumoniasurgical procedures operativemedicine.anatomical_structureChild PreschoolAcute DiseasebusinessEx vivoFollow-Up StudiesBiology of Blood and Marrow Transplantation
researchProduct

Enhanced Recovery after Implementation of Surgery Protocol in Living Kidney Donors: The ISMETT Experience

2019

Abstract Introduction Laparoscopic living donor nephrectomy (LLDN) has become the standard procedure for living kidney transplantation. Enhanced recovery after surgery (ERAS) is a multimodal perioperative management aimed at facilitating rapid patient recovery after major surgery by modifying the response to stress induced by exposure to surgery. This association can further reduce hospital stay, surgical stress, and perioperative morbidity of living kidney donors. Material and methods In this retrospective analysis conducted at our institute, we compared the first 21 patients who underwent LLDN enrolled with the ERAS protocol with 55 patients who underwent LLDN with the fast-track protocol…

AdultMalemedicine.medical_specialtySurgical stressNephrectomyPatient ReadmissionPostoperative ComplicationsEnhanced recoveryISMETTLiving DonorsMedicineHumansKidney transplantationAgedRetrospective StudiesProtocol (science)TransplantationKidneybusiness.industryRetrospective cohort studyPerioperativeRecovery of FunctionLength of StayMiddle Agedmedicine.diseaseKidney TransplantationSurgerymedicine.anatomical_structureTissue and Organ HarvestingSurgeryFemaleLaparoscopybusiness
researchProduct

Incidence of Cardiovascular Events after Nephrectomy - A Single Centre, Matched Pair Analysis between Donor and Tumour Nephrectomy in a Long Term Fol…

2016

<b><i>Introduction:</i></b> The study aimed to compare the incidence of cardiovascular events (CVEs) after donor nephrectomy (DN) and radical tumor nephrectomy (RN), according to an estimated glomerular filtration rate (eGFR), were evaluated over time. <b><i>Materials and Methods:</i></b> Follow-up was collected for DN who underwent surgery from 1998 to 2007 for CVE and renal function. All DN were matched for age to patients treated by RN or adenoma enucleation (control group), who were eligible for DN. eGFR was estimated using the Cockgroft-Gould formula. Patients with preoperative comorbidities were excluded. <b><i>Results:</i…

AdultMalemedicine.medical_specialtyTime FactorsAdenomaUrologymedicine.medical_treatmentMatched-Pair AnalysisEnucleation030232 urology & nephrologyUrologyRenal functionNephrectomy03 medical and health sciences0302 clinical medicinePostoperative ComplicationsInterquartile rangemedicineHumans030212 general & internal medicineRisk factorStrokebusiness.industryIncidence (epidemiology)IncidenceMiddle Agedmedicine.diseaseNephrectomyKidney NeoplasmsTissue DonorsSurgeryCardiovascular DiseasesFemalebusinessFollow-Up StudiesUrologia internationalis
researchProduct

A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine

2005

In this randomized trial renal transplant recipients were treated with basiliximab, everolimus 3 mg/day, low-dose CsA. At transplantation, patients were randomized to stop steroids at the seventh day (group A) or to continue oral steroids in low doses (group B). Of the 113 patients enrolled, 65 were randomized to group A and 68 to group B. All patients were followed for 2 years. During the study 28 (43%) group A patients required reintroduced corticosteroids. One patient died, in group B. The Graft survival rate was 97% in group A and 90% in group B. There were more biopsy-proven rejections in group A (32% vs 16%; P = .044). The mean creatinine clearance was 54 +/- 21 mL/min in group A vs 5…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentBasiliximabUrologyRenal functionGroup AGroup Blaw.inventionRandomized controlled triallawAdrenal Cortex HormonesHLA AntigensmedicineLiving DonorsHumansEverolimuscyclosporineAgedSirolimusTransplantationEverolimusbusiness.industryHistocompatibility TestingeverolimuMiddle Agedrenal transplantationKidney TransplantationSurgerySteroid Avoidance in Renal Transplant PatientsTransplantationRegimentrial; transplant; immunosoppressivesteroid avoidanceSurgeryFemalebusinessImmunosuppressive Agentsmedicine.drugFollow-Up Studies
researchProduct

Psychological Conflicts Between Relatives During the Long-Term Course After Successful Living Organ Donation

2008

The German transplantation law prefers living organ donation between close relatives and spouses, which is assumed to guarantee unequivocal altruistic motivation. Since 2001, 68 recipient-donor-pairs, who aspired to have a renal or liver transplantation, underwent a systematic psychosomatic evaluation. Meanwhile, 43 transplantations were performed including 34 renal and 9 liver cases. Seventeen recipient-donor-pairs were readministered evaluations by the department of psychosomatic medicine after 1 to 6 years after transplantation for long-term follow-up. In 10 cases of medically successful transplantation, we identified severe conflicts between donor, recipient, and next-of-kin. Major conf…

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentFamily conflictStalemateLiver transplantationNephrectomyConflict PsychologicalInterviews as TopicInterpersonal relationshipLiving organ donationLiving DonorsmedicineHepatectomyHumansFamilyInterpersonal RelationsOrgan donationSpousesTransplantationbusiness.industryPsychosomatic medicineMiddle AgedSurgeryTransplantationFamily medicineFemaleSurgerybusinessFollow-Up StudiesTransplantation Proceedings
researchProduct

Crucial Role of Extended Criteria Donors in Deceased Donor Single Kidney Transplantation to Face Chronic Shortage in the Heart of the Mediterranean B…

2019

Background: The gap between organ availability and patients on the waiting list for deceased donor kidney transplants has resulted in the wide use of extended criteria donors (ECDs).We aimed to compare the surgical outcomes of single kidney transplantation (KT) performed at our institute with standard criteria donor (SCD) or ECD grafts, according to the Organ Procurement and Transplantation Network definition. Patients and methods. Our retrospective analysis studied 115 adult recipients of KT from January 2016 to July 2018, with kidney grafts procured from adult donors after brain or circulatory death, performed at our institute. Among the 2 recipients’ groups, we compared the incidence of …

AdultMalemedicine.medical_specialtyTissue and Organ ProcurementDelayed Graft FunctionSingle CenterMedicineHumansSurvival analysisKidney transplantationRetrospective StudiesTransplantationKidneyContinental Population Groupsbusiness.industryIncidence (epidemiology)IncidenceGraft SurvivalRacial GroupsRetrospective cohort studyMiddle Agedmedicine.diseaseKidney TransplantationSurvival AnalysisTissue DonorsSurgeryTransplantationsurgical procedures operativemedicine.anatomical_structureTreatment OutcomeSurgeryFemalebusinessBody mass indexTransplantation proceedings
researchProduct

A proposal for an anonymous living organ donation in Germany.

2003

Abstract In Germany, living organ donation of paired and usually not regenerating organs is restricted by law to related individuals, as well as persons who ‘obviously entertain an especially intimate personal relationship'. When this law was adopted in 1997, the intention of the legislator was to guarantee the free will of the donor and to exclude any trade of organs. Since then the transplantation of cadaveric organs has not increased. Additional organs were donated from living donors. However, for a number of reasons only a limited array of transplantation centers use living organ donation as a supply facing a steadily increasing number of patients with chronic renal failure. Living orga…

AdultMalemedicine.medical_specialtyTissue and Organ ProcurementLife qualityOrgan transplantationPathology and Forensic MedicineABO Blood-Group SystemTherapeutic approachLiving organ donationGermanyLiving DonorsMedicineHumansIntensive care medicineKidney transplantationbusiness.industryPersonal relationshipMiddle Agedmedicine.diseaseAltruismKidney TransplantationSurgeryTransplantationIssues ethics and legal aspectsBlood Group IncompatibilityChronic renal failurebusinessLegal medicine (Tokyo, Japan)
researchProduct

Inflammation and endothelial activation are linked to renal function in long-term kidney transplantation

2006

The aim of this study was to investigate the relationships between inflammation and adhesion molecules in long-term kidney transplantation. We measured serum concentrations of tumor necrosis factor-alpha (TNFalpha) and intercellular and vascular cell adhesion molecules (ICAM-1 and VCAM-1) in 35 renal transplant recipients (mean age of transplantation 5 +/- 3 years) and in 35 chronic renal insufficiency (CRI) patients; twenty-six healthy subjects were enrolled as controls. Transplanted showed higher values than controls of TNFalpha (P < 0.0001), ICAM-1 (P < 0.0001), and VCAM-1 (P < 0.0001). CRI group as well exhibited higher concentrations than controls of TNFalpha (P < 0.0001), ICAM-1 (P < …

AdultMalemedicine.medical_specialtyVascular Cell Adhesion Molecule-1Renal functionInflammationKidney Function TestsEndothelial activationchemistry.chemical_compoundInternal medicineCadavermedicineHumansInflammation endothelial activation kidney transplantationKidney transplantationInflammationTransplantationCreatinineTumor Necrosis Factor-alphabusiness.industryMiddle AgedIntercellular Adhesion Molecule-1medicine.diseaseKidney TransplantationTissue DonorsTransplantationEndocrinologyBlood pressurechemistryTumor necrosis factor alphaEndothelium Vascularmedicine.symptombusinessBiomarkersGlomerular Filtration Rate
researchProduct

Allogenic simple limbal epithelial transplantation (alloSLET) from cadaveric donor eyes in patients with persistent corneal epithelial defects

2020

Background/aimTo describe the clinical outcome of allogenic simple limbal epithelial transplantation (alloSLET) utilising tissue from cadaveric donor eyes after failed re-epithelialisation of the corneal surface.MethodsMedical records of 14 eyes from 14 patients treated for persistent corneal epithelial defects with alloSLET were reviewed. The primary outcome measure was complete epithelialisation of the corneal surface. Secondary outcome measures were best corrected visual acuity (BCVA) and postoperative side effects due to surgery or medical therapy.ResultsOf the 14 eyes, 7 received alloSLET only and 7 alloSLET together with penetrating keratoplasty (PK). Thirteen (92.9%) of 14 eyes had a…

AdultMalemedicine.medical_specialtygenetic structuresPrednisoloneVisual AcuityLimbus CorneaeCorneal DiseasesCellular and Molecular NeuroscienceRe-EpithelializationCorneaOphthalmologyCadaverHumansMedicineEffective treatmentIn patientAgedRetrospective StudiesCorneal epitheliumAged 80 and overbusiness.industryEpithelium CornealCadaveric donorMiddle AgedMycophenolic AcidAllograftsTissue Donorseye diseasesSensory SystemsTransplantationOphthalmologyTreatment Outcomemedicine.anatomical_structureFemalesense organsbusinessBandage contact lensOcular surfaceImmunosuppressive AgentsBritish Journal of Ophthalmology
researchProduct